A parent comes away from a broad allergy panel with a list of fourteen foods their child is apparently allergic to, several of which the child eats regularly without incident. This scenario is common enough that allergy specialists have a shorthand for it, and it is not caused by a faulty test. The panel measured exactly what it was designed to measure. The problem is that what it measures is not what the word “allergy” means to the person reading the report.
Both of the standard tests, blood specific IgE and skin prick testing, detect the presence of immunoglobulin E antibodies directed against a particular protein. The presence of those antibodies is called sensitisation. Allergy is something more: sensitisation plus a reproducible clinical reaction when the substance is encountered. Plenty of people are sensitised to things they can eat, touch or breathe with no consequence whatever, and the gap between the two states is where most of the confusion in allergy testing lives.
That does not make the tests unhelpful. Used to check a specific suspicion raised by a specific history, they are informative and often decisive. Used to survey a long list of substances in someone with vague symptoms, they generate results that are difficult to interpret and can lead to unnecessary avoidance of foods that were never a problem, which carries its own nutritional and social costs and may even increase risk over time.
This piece explains what each test physically does, why they disagree with each other, and where the answer has to come from somewhere else entirely.
Key takeaways
- Both tests detect IgE antibodies, which indicates sensitisation rather than clinical allergy.
- A positive result in someone who tolerates the food is common and usually means nothing on its own.
- Skin prick tests read a live reaction in minutes; blood tests measure antibody concentration in serum.
- Larger reactions and higher antibody levels raise the probability of true allergy but do not predict severity.
- A supervised oral challenge remains the only way to settle an uncertain case definitively.
What Specific IgE Antibodies Represent
Immunoglobulin E is the least abundant antibody class in blood, and in evolutionary terms it appears to have arisen to deal with parasites. Its distinguishing feature is where it sits. Rather than circulating freely and waiting to meet its target, IgE binds with high affinity to receptors on the surface of mast cells in tissue and basophils in blood, arming those cells in advance.
Each mast cell ends up coated with IgE molecules of many different specificities. When an allergen arrives and binds two adjacent IgE molecules of the same specificity, cross-linking their receptors, the cell degranulates. It releases histamine and other preformed mediators within seconds and begins synthesising further mediators over the following minutes. Those mediators dilate blood vessels, increase their permeability, contract smooth muscle and stimulate nerve endings, which is why allergic reactions produce the specific combination of swelling, itch, wheeze and, in severe cases, circulatory collapse.
Sensitisation is the state of having produced specific IgE against a protein and having it loaded onto mast cells. It develops after exposure and requires a particular immune response to that protein rather than the tolerant response most people mount. The important point is that sensitisation is necessary for an IgE-mediated allergic reaction but not sufficient for one. Whether the reaction occurs depends on how much specific IgE is present relative to other antibodies, how tightly it binds, which parts of the protein it recognises, how many mast cells are involved, how readily the allergen reaches them intact, and how reactive the individual’s mast cells happen to be. A laboratory measures one of those variables.
Sensitisation Is Not the Same as Allergy
The practical consequence is that a positive test in someone who eats the food comfortably is not a contradiction and not an error. It is an accurate detection of antibodies that are not producing a clinical effect.
Population studies consistently find that sensitisation is considerably more common than allergy. For several common foods, the proportion of people with detectable specific IgE substantially exceeds the proportion who react on a controlled challenge. The gap is widest for foods with heavy cross-reactivity, discussed further below, and for people who have other allergic conditions such as eczema or hay fever and tend to produce IgE against many things.
This is why history comes first and testing second. The information that makes a result interpretable includes what was eaten or encountered, how long afterwards symptoms began, what those symptoms were, whether they have happened more than once with the same trigger, and whether the substance has been tolerated on other occasions. Immediate IgE-mediated reactions typically begin within minutes to about two hours and involve skin, gut, airway or circulation. Symptoms that begin the next day, or that consist of fatigue and bloating alone, are unlikely to be IgE-mediated, and an IgE test is the wrong instrument for investigating them.
Testing without that history inverts the logic. Rather than testing a hypothesis, it generates hypotheses, and in a test with imperfect specificity applied to many substances at once, most of those hypotheses will be wrong.
How Skin Prick Testing Compares Physically
Skin prick testing works from the other end of the same mechanism. Instead of measuring antibody in serum, it provokes a small, controlled version of the reaction and observes it.
A drop of standardised allergen extract is placed on the forearm or back, and a lancet introduces a minute quantity into the outermost skin layer. If mast cells there carry specific IgE for that allergen, they degranulate locally. Histamine dilates the surrounding capillaries and makes them leaky, producing a raised pale wheal surrounded by a red flare within about fifteen minutes. The wheal diameter is measured and compared against two controls: histamine, which should produce a reaction and confirms the skin is capable of responding, and a saline or diluent control, which should not and detects skin that reacts to the trauma of the prick itself.
| Feature | Skin prick test | Blood specific IgE |
|---|---|---|
| What is measured | Live mast cell response in skin | Antibody concentration in serum |
| Result available | About fifteen to twenty minutes | Days, after laboratory processing |
| Affected by antihistamines | Yes, must be stopped beforehand | No |
| Usable with widespread eczema | Often not, needs clear skin | Yes |
| Small risk of systemic reaction | Yes, low but real | No |
| Number of allergens per session | Limited by skin area | Limited only by ordering |
| Quantitative output | Wheal size in millimetres | Concentration in defined units |
Neither test is straightforwardly superior. Skin testing reflects the whole effector pathway rather than antibody alone, and it is immediate and inexpensive. It requires trained staff, stopping antihistamines for several days, and skin clear enough to read, and it should be done where anaphylaxis can be treated. Blood testing is unaffected by medication or skin disease, is easily repeated, and gives a number that can be tracked over time. Its result is a concentration in a tube, one step further removed from the tissue where reactions actually happen.
When the two disagree, which is not unusual, the history decides. Agreement between both tests and a convincing history is strong evidence; agreement between the two tests against a history of comfortable tolerance usually means sensitisation without allergy.
Why Broad Panels Generate False Alarms
The arithmetic that undermines broad panels is the same arithmetic that undermines any multi-test screen. Each individual test has some rate of positives in people who are not clinically allergic. Run enough of them in a person whose prior probability of allergy is low, and positives accumulate that have nothing to do with their symptoms.
Two features make this worse in allergy testing than in most fields. The first is that the underlying rate of positives is not small; sensitisation is genuinely common, so these are largely true detections of antibody being over-interpreted as disease. The second is cross-reactivity, which means a single sensitisation can light up many panel entries related by protein family rather than by any real risk.
The harms are concrete. Foods removed from a diet on the strength of a panel result are often nutritionally important, and unnecessary exclusion in a child can affect growth and complicate family life considerably. There is also a mechanistic reason for caution beyond nutrition: evidence has moved firmly toward early and continued exposure supporting tolerance for several common allergens, so removing a tolerated food may raise the chance of developing a genuine allergy to it later. Reintroduction after a long gap then carries its own risk and needs supervision.
A separate category deserves naming because it appears in the same market. Tests measuring IgG or IgG4 antibodies to foods, sold widely as intolerance panels, detect a normal immune response to things a person eats. Allergy organisations have been consistent that these results do not identify food intolerance or allergy, and that the elimination diets built on them lack a rational basis.
Component-Resolved Diagnostics Explained
The most useful development in allergy testing addresses the interpretation problem directly. Rather than testing against a crude extract containing every protein in a food, component testing measures IgE against individual purified proteins from it.
This matters because the proteins within one food behave very differently. Some are stable molecules that survive heating and digestion, reach the gut intact and can provoke systemic reactions. Others are fragile, denature with cooking or stomach acid, and typically cause only local itching in the mouth. A conventional extract test returns one answer for the whole food and cannot distinguish these. Component testing shows which protein the antibodies recognise.
The clinical value is in the pattern. Sensitisation to a food’s stable storage proteins is associated with a higher probability of true, potentially significant allergy. Sensitisation only to its fragile, pollen-related proteins usually indicates cross-reactivity from a pollen allergy, with mild and localised symptoms. This distinction changes advice substantially, and it is the single most common reason a specialist orders component testing rather than a broader panel.
Component testing also helps determine whether a person allergic to one substance is likely to react to a related one, and it contributes to decisions about immunotherapy, where knowing which protein drives the response affects whether a particular extract is appropriate.
Cross-Reactivity Between Pollens and Foods
Cross-reactivity is the reason many panels look alarming, and understanding it removes much of the alarm.
An IgE antibody recognises a small three-dimensional patch on a protein’s surface, not the protein as a whole and certainly not the food it came from. Proteins performing similar jobs in related organisms have similar structures, so an antibody raised against a protein in birch pollen may bind a structurally similar protein in an apple. The immune system is not confused; the two patches genuinely resemble each other.
The best-known example is pollen food syndrome. Someone sensitised to certain tree pollens finds that raw apples, stone fruits, carrots, celery or hazelnuts make the mouth and throat itch. The responsible proteins are heat-labile, so the same person usually tolerates the cooked versions without trouble, and symptoms remain confined to the mouth because the protein is destroyed before it can be absorbed. On a broad panel this appears as sensitisation to a long list of fruits, vegetables and nuts, which looks far more serious than it is.
Similar patterns run through other groups. Shellfish species share a muscle protein that accounts for much of the cross-reactivity within that group. Related tree nuts share storage proteins. Dust mite sensitisation cross-reacts with proteins in shellfish and some insects. A carbohydrate structure present on many plant and insect proteins produces antibodies that bind widely and, in most cases, cause no symptoms at all, though they generate a great many positive extract tests.
Cross-reactivity therefore explains both why panels light up and why component testing helps: the panel reports which foods contain something the antibodies bind, while component testing reports which protein family is involved and therefore how much it matters.
Where Oral Food Challenges Remain the Standard
When history and testing do not agree, or when a food avoided for years needs to be reassessed, the only test that answers the actual question is giving the person the food under medical supervision.
An oral food challenge is done in a setting equipped to treat anaphylaxis, with the food given in gradually increasing amounts at set intervals while symptoms and observations are monitored. If a reaction occurs it is treated immediately, and the diagnosis is established. If the full portion is tolerated, clinical allergy is excluded and the food can return to the diet, which is frequently the outcome and frequently a considerable relief.
The reason this remains the reference standard is that it measures the endpoint everyone cares about. Antibody concentration and wheal diameter are correlates; the challenge is the event itself. It is resource-intensive, requires several hours and trained staff, and carries genuine risk, which is why it is reserved for cases where the answer will change management and where the probability of a severe reaction has been assessed as acceptable.
Test results do inform that decision. Higher specific IgE concentrations and larger wheals are associated with a greater probability of reacting, and specialists use that relationship to judge who is likely to pass a challenge. What those numbers do not do is predict how severe a reaction would be. Severity depends on dose, the form the food is in, exercise, illness, alcohol and other cofactors, and people with modest test results have had serious reactions while others with striking results have tolerated the food.
Frequently asked questions
Can allergy tests predict how severe a reaction will be?
No, and this is the most consequential limitation. Antibody concentration and wheal size relate to the probability that a person will react at all, and specialists use them in that way. They do not indicate what a reaction would look like. Severity is determined by how much was eaten, how the food was prepared, and cofactors such as exercise, infection, alcohol and certain medications, none of which the test can see. This is why an adrenaline device is prescribed on the basis of clinical assessment and reaction history rather than on a number.
Why did a food test positive when my child eats it regularly?
Because the test detected sensitisation, and sensitisation without clinical allergy is common, particularly in children with eczema who tend to produce IgE against many proteins. A food eaten regularly and reliably tolerated is, by the only standard that matters, not one the child is allergic to. Established practice is not to remove it. Removing a tolerated food carries nutritional and social costs and may increase the risk of genuine allergy developing during the gap, after which reintroduction becomes harder and needs supervision.
Do I need to stop antihistamines before testing?
Before skin prick testing, yes. Antihistamines block the receptor that produces the wheal, so they can suppress the reaction and generate a falsely negative result. The usual instruction is to stop them for several days beforehand, and the histamine control on the test detects the problem if it has not been done. Blood specific IgE testing is unaffected, which is one of its practical advantages, along with its usability in people whose skin is too inflamed to test or who cannot safely pause their medication.
What is the difference between an IgE test and a food intolerance test?
They measure different antibodies and mean different things. Specific IgE testing detects the antibody class responsible for immediate allergic reactions and is a validated part of allergy diagnosis when interpreted with a history. Tests measuring IgG or IgG4 against foods detect a normal immune response to things a person eats, present in healthy people, and allergy organisations have consistently advised that they do not diagnose intolerance or allergy. Genuine intolerances, such as lactose intolerance, have their own specific tests based on quite different mechanisms.
How often should allergy testing be repeated in a child?
It depends on the allergen. Several childhood food allergies, notably to milk and egg, are commonly outgrown, so periodic reassessment is standard practice and falling antibody levels can indicate that tolerance is developing. Allergies to peanut, tree nuts and shellfish persist more often, though not always. Retesting is usually timed by age and by the trajectory of previous results, and a fall in the number is what prompts consideration of a supervised challenge rather than an assumption that the allergy has resolved.
The most useful reframing is that neither test diagnoses allergy. Each contributes one measurement to a picture whose outline comes from what actually happened when the substance was encountered. Start with the story, test the specific suspicion it raises, treat an unexpected positive as a question rather than an answer, and reserve broad panels for situations where someone has already thought about what a positive would mean. Done that way, these tests are precise and genuinely useful. Done in reverse, they produce long lists of foods nobody needed to avoid.
This is education, not medical advice. Laboratory results only carry meaning alongside your symptoms, history and examination. Talk to a qualified clinician about your own results before changing anything about your care or supplements.
